Global Hormone Replacement Therapy Market
According to the report "Hormone Replacement Therapy Market”, published by Market Data Forecast, the
global market is projected to reach USD 22.31 billion by 2021, at a CAGR of 7.21% from 2016 to 2021.
Hormone replacement therapy (HRT) is employed in patients suffering from declining levels of hormones with
the right administration of hormones into the body. These therapies are generally meted out to women
undergoing menopause. Estrogen is among the most commonly administered hormones. However,
progesterone and testosterone are also administered when needed.
Growing awareness on post-menopausal hazards, reimbursement policies, novel formulations, rise in unmet
medical needs which require the employment of hormone therapy, benefits like lower risk of fractures are the
few factors propelling the growth of global hormone replacement therapy market.
Responsible for more than half of the market revenues, the estrogen replacement therapy segment dominates
the global HRT market. The largest consumers of estrogen replacement therapy are post-menopausal women.
North America dominated the market, where the majority of the contribution was from the USA owing to the
well-established healthcare system. While, the market in the APAC region is expected to witness a rapid
growth during the forecast period.
Global Market for Hormone Replacement Therapy is segmented by Hormone Type, Route of
Administration and Region
1. By Hormone Type
Estrogen Replacement Therapy
Growth Hormone Replacement Therapy
Thyroid Replacement Therapy
Others
2. By Route of Administration
Oral
Parenteral
Transdermal
Others
3. By Geography
North America
Europe
Asia-Pacific
+1 888-702-9626 | www.marketdataforecast.com | [email protected]